Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
UCMSC for Bronchopleural Fistula
NCT02961725Phase 1Unknown
- Sponsor
- The Second Affiliated Hospital of Fujian Medical University
- Start
- Apr 2016
- Primary completion
- Apr 2017
- Modality
- Stem Cell Therapies
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of human umbilical cord mesenchymal stem cells in bronchopleural fistula (BPF), sponsored by The Second Affiliated Hospital of Fujian Medical University. Primary endpoint: Closure of the fistula at 24 weeks. Status: unknown.
02
Drugs
human umbilical cord mesenchymal stem cells
03
Conditions
bronchopleural fistula (BPF)
Beyond the preview
Go deeper on NCT02961725.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02961725.